医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
33期
99-99,100
,共2页
朱海文%陈龙云%侍红泰%裴冬%毛义翔%陈斌
硃海文%陳龍雲%侍紅泰%裴鼕%毛義翔%陳斌
주해문%진룡운%시홍태%배동%모의상%진빈
局部晚期胰腺癌%调强放疗%高强度聚焦超声热疗
跼部晚期胰腺癌%調彊放療%高彊度聚焦超聲熱療
국부만기이선암%조강방료%고강도취초초성열료
Local y advanced pancreatic cancer%Intensity-modulated radiotherapy%High intensity focused ultrasound
目的:探讨调强放疗(IMRT)联合高强度聚焦超声热疗治疗局部晚期胰腺癌的疗效及副反应。方法2008年10月~2011年9月对45例Ⅲ、Ⅳa期胰腺癌患者进行调强放疗,1次/d,5次/w,高强度聚焦超声热疗,隔日1次,共3~6次。评估肿瘤的缓解率,1年和2年生存率,临床受益率及副反应。结果总有效率(CR+PR)分别为73.3%,中位生存期14.2个月,1、2年生存率为53.3%、26.7%,毒副作用:白细胞减少、恶心呕吐。结论调强放疗联合高强度聚焦超声热疗对局部晚期胰腺癌有一定疗效,副作用少,值得进一步研究。
目的:探討調彊放療(IMRT)聯閤高彊度聚焦超聲熱療治療跼部晚期胰腺癌的療效及副反應。方法2008年10月~2011年9月對45例Ⅲ、Ⅳa期胰腺癌患者進行調彊放療,1次/d,5次/w,高彊度聚焦超聲熱療,隔日1次,共3~6次。評估腫瘤的緩解率,1年和2年生存率,臨床受益率及副反應。結果總有效率(CR+PR)分彆為73.3%,中位生存期14.2箇月,1、2年生存率為53.3%、26.7%,毒副作用:白細胞減少、噁心嘔吐。結論調彊放療聯閤高彊度聚焦超聲熱療對跼部晚期胰腺癌有一定療效,副作用少,值得進一步研究。
목적:탐토조강방료(IMRT)연합고강도취초초성열료치료국부만기이선암적료효급부반응。방법2008년10월~2011년9월대45례Ⅲ、Ⅳa기이선암환자진행조강방료,1차/d,5차/w,고강도취초초성열료,격일1차,공3~6차。평고종류적완해솔,1년화2년생존솔,림상수익솔급부반응。결과총유효솔(CR+PR)분별위73.3%,중위생존기14.2개월,1、2년생존솔위53.3%、26.7%,독부작용:백세포감소、악심구토。결론조강방료연합고강도취초초성열료대국부만기이선암유일정료효,부작용소,치득진일보연구。
Objective To ef icacy and safety of intensity-modulated radiotherapy ( IMRT )combined with high intensity focused ultrasound (HIFU) in treating patients with local pancreatic cancer. Methods Between October 2008 and December 2011,15patients withⅢ、Ⅳa stage pancreatic adenocarcinoma were accepted IMRT combined with HIFU.IMRT 2Gy/F,50-60Gy/25-30F/5-6W, HIFU 3~6F.The tumor remission rates, survival rates, clinical benefit response (CBP) and side ef ects were analyzed. Results The total ef ective rat (CR+PR)73.3.8%,The median survival time was 14.2 months, the 1 year,2yearsurvival rat was53.3%、26.7%.Conclusion While preliminary results indicate promising results with IMRT using HIFU and chemotherapy for local y advanced pancreatic cancer, the complication rate significantly. Reliable devived from mature phaseⅢtrials are greatly needed.